Original Research

Sarilumab monotherapy compared with adalimumab monotherapy for the treatment of moderately to severely active rheumatoid arthritis: an analysis of incremental cost per effectively treated patient

Fournier M, Chen C, Kuznik A, Proudfoot C, Mallya UG, Michaud K

ClinicoEconomics and Outcomes Research 2019, 11:117-128

Published Date: 5 February 2019